Marshall Wace’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Buy |
269,284
+67,384
| +33% | +$2.94M | 0.01% | 713 |
|
|
2025
Q1 | $5.53M | Buy |
201,900
+195,065
| +2,854% | +$5.34M | 0.01% | 941 |
|
|
2024
Q4 | $275K | Sell |
6,835
-110,846
| -94% | -$4.46M | ﹤0.01% | 2105 |
|
|
2024
Q3 | $5.57M | Sell |
117,681
-258,881
| -69% | -$12.3M | 0.01% | 880 |
|
|
2024
Q2 | $11.2M | Sell |
376,562
-196,364
| -34% | -$5.86M | 0.02% | 619 |
|
|
2024
Q1 | $23M | Buy |
+572,926
| New | +$23M | 0.04% | 405 |
|
|
2023
Q4 | – | Sell |
-54,837
| Closed | -$762K | – | 2081 |
|
|
2023
Q3 | $762K | Sell |
54,837
-209,081
| -79% | -$2.91M | ﹤0.01% | 1330 |
|
|
2023
Q2 | $6.07M | Buy |
+263,918
| New | +$6.07M | 0.01% | 808 |
|
|
2021
Q2 | – | Sell |
-14,698
| Closed | -$571K | – | 2322 |
|
|
2021
Q1 | $571K | Buy |
+14,698
| New | +$571K | ﹤0.01% | 1599 |
|